Market Outlook

By 2035, the U.S. Dialysis Devices Market is expected to reach approximately USD 20.03 billion, expanding at a CAGR of 8.76% during the forecast period 2026-2035. The market is estimated at USD 8.65 billion in 2025, with historical analysis covering 2021-2024. Values in this report are expressed in USD billions. The scope includes hemodialysis machines, dialyzers, blood tubing sets, needles, dialysate delivery and water-treatment systems, peritoneal dialysis cyclers and transfer sets, dialysis solutions and related consumables, continuous kidney replacement therapy systems, acute dialysis platforms, and dialysis vascular-access devices. Dialysis service revenue, pharmaceuticals, laboratory testing, and kidney transplantation are excluded from the device-market valuation.

The U.S. dialysis device industry is a life-sustaining, high-utilization medical technology market with unusually predictable recurring demand. More than 35 million U.S. adults are estimated to have chronic kidney disease, while the population living with kidney failure exceeded 831,000 in 2023. Approximately 131,500 people entered kidney failure treatment during that year. Most patients requiring renal replacement therapy receive dialysis rather than an immediate transplant, creating a substantial installed base of dialysis stations, machines, water systems, cyclers, cartridges, filters, bloodlines, needles, catheters, and treatment-specific disposables. Unlike many capital-equipment markets, dialysis combines long equipment replacement cycles with dense recurring-consumable utilization, which supports revenue resilience even when hospital capital budgets tighten.

The market is moving beyond conventional three-times-weekly in-center hemodialysis toward a broader renal-support ecosystem that includes home hemodialysis, automated peritoneal dialysis, high-volume hemodiafiltration, portable acute-care systems, continuous kidney replacement therapy, remote patient management, integrated water generation, cybersecurity-enabled connectivity, and data-driven treatment personalization. This transition changes the basis of competition. Buyers no longer evaluate only machine price or dialyzer cost. They assess nursing time, infrastructure requirements, training burden, treatment flexibility, consumable pull-through, alarm frequency, service uptime, electronic medical record integration, home-program retention, and the total cost per delivered treatment.

The historical market expanded from an estimated USD 6.18 billion in 2021 to USD 7.78 billion in 2024. Growth accelerated as dialysis utilization normalized after the pandemic, hospitals rebuilt acute dialysis capacity, home modalities gained greater clinical attention, supply chains recovered, and manufacturers introduced more compact systems with integrated water and digital functions. The market reached USD 8.65 billion in 2025 as dialysis providers replaced aging machines, health systems internalized selected acute dialysis services, peritoneal dialysis programs expanded, and higher-value consumables such as high-flux dialyzers, specialized membranes, antimicrobial access products, and continuous therapy cartridges increased their contribution.

The market forecast is an analyst-derived device estimate based on treatment population, facility count, installed equipment, replacement cycles, home-modality adoption, acute renal replacement utilization, recurring disposable intensity, and prevailing U.S. pricing. The 8.76% CAGR is aggressive but defensible because value growth will be driven not only by patient volume but also by technology mix. The introduction of hemodiafiltration-capable systems, next-generation connected machines, home-use platforms, and more sophisticated acute kidney injury devices increases average revenue per treatment environment. At the same time, the recurring nature of dialyzers, bloodlines, solutions, transfer sets, cartridges, and access products provides a durable base that reduces dependence on one-time capital orders.

 

Introduction

According to the U.S. Dialysis Devices Market Report, the industry is shaped by a rare combination of chronic disease burden, federal reimbursement protection, high treatment frequency, concentrated provider purchasing, clinical labor constraints, and continuous demand for consumables. Dialysis is operationally different from most medical procedures. A patient receiving maintenance hemodialysis typically requires multiple treatments every week, while peritoneal dialysis patients use supplies daily. This creates a large recurring product stream and makes reliability, distribution continuity, and service response central to procurement decisions.

The U.S. market is supported by a large care-delivery footprint. CMS expects Medicare to pay for renal dialysis services across approximately 7,600 ESRD facilities in 2026, with a base payment rate of USD 281.71 per treatment. The bundled reimbursement structure places direct economic pressure on providers because machines, supplies, drugs, staffing, utilities, facility overhead, and quality obligations must be managed within a defined payment environment. Device vendors that reduce operating complexity, water consumption, labor time, unplanned maintenance, or treatment interruptions can therefore create value even when their acquisition price is higher than a conventional alternative.

The market is not limited to freestanding dialysis clinics. Hospitals use intermittent hemodialysis, sustained low-efficiency dialysis, and continuous kidney replacement therapy in intensive care units, emergency departments, transplant programs, cardiac surgery, oncology, and complex medical care. Home settings use compact hemodialysis systems, automated peritoneal dialysis cyclers, remote monitoring platforms, fluid-management tools, and extensive disposable kits. Vascular-access products link the device market to interventional radiology, surgery, nephrology, and infection-prevention workflows. Water-treatment equipment and dialysate preparation systems form another critical infrastructure layer because treatment quality depends on consistent fluid purity and system maintenance.

The underlying disease pipeline remains large. Diabetes and hypertension continue to account for roughly two-thirds of new kidney failure cases. The aging U.S. population, obesity, cardiovascular disease, and survival improvements among medically complex patients sustain the number of people who may eventually require renal replacement therapy. Although kidney-protective drug classes can delay disease progression for some patients, they do not eliminate the dialysis demand pool. Delayed progression may shift the timing and age profile of dialysis initiation, but the size of the CKD population means that absolute treatment demand remains substantial.

From 2026 to 2035, the most important strategic shift will be the movement from modality-specific equipment toward connected renal-care platforms. Health systems and dialysis providers will increasingly favor products that can be deployed across hospital, clinic, and home environments; use standardized consumables; simplify training; integrate with clinical information systems; support remote oversight; and generate auditable treatment data. Manufacturers able to combine capital equipment, recurring disposables, clinical support, digital infrastructure, and reimbursement-oriented economic evidence will be better positioned than companies selling isolated products.

 

Key Market Drivers: What’s Fueling the U.S. Dialysis Devices Market Boom?

The first major driver is the scale and persistence of chronic kidney disease. An estimated 14% of U.S. adults have CKD, and most affected individuals are unaware of their condition. Kidney failure is the end of a long disease pathway, but the population entering renal replacement therapy remains large: roughly 360 people begin dialysis treatment on an average day. The 2023 kidney failure population reached a record level, indicating that improvements in prevention have not yet reduced the absolute need for dialysis devices. Each additional long-term dialysis patient creates recurring demand for hundreds of disposable components and repeated machine utilization over the course of a year.

A second driver is the protected reimbursement framework surrounding ESRD care. Medicare coverage for kidney failure gives the dialysis market a more stable demand base than many elective device categories. For 2026, the ESRD prospective payment system base rate increased from USD 273.82 to USD 281.71, and CMS projected approximately USD 6.0 billion in payments to roughly 7,600 facilities. The payment environment is not generous enough to remove cost pressure, but it provides predictable treatment economics. This favors technologies that can document lower labor requirements, reduced infrastructure cost, fewer interruptions, better consumable management, and stronger quality performance.

A third driver is the expansion of home dialysis. The share of new kidney failure patients starting peritoneal dialysis reached an all-time high of 14.1% in 2023. Home hemodialysis remains smaller, but it is strategically important because it can improve schedule flexibility, reduce patient travel, and create alternatives where clinic capacity is constrained. Home programs require cyclers or compact machines, connectivity, training systems, delivery logistics, consumable storage, and technical support. Growth in home modalities therefore creates a broader revenue pool than the machine alone. The largest commercial opportunity lies with platforms that improve patient confidence and reduce home-program failure, not simply those that receive a home-use indication.

A fourth driver is hospital demand for more controllable acute dialysis economics. Many hospitals historically outsourced portions of acute dialysis delivery or used equipment that required substantial plumbing, water treatment, and specialist staffing. Compact systems with integrated purification and simplified setup allow hospitals to evaluate insourcing models, deploy dialysis across multiple units, and reduce dependence on fixed dialysis rooms. ICU demand is also supported by acute kidney injury associated with sepsis, major surgery, shock, cardiac procedures, trauma, and multi-organ failure. Continuous kidney replacement therapy generates high recurring cartridge and fluid consumption, making acute-care renal support a strategically attractive submarket.

A fifth driver is the modernization of dialysis therapy itself. High-flux membranes are established, but the U.S. is beginning a new adoption cycle around online high-volume hemodiafiltration. FDA clearance and U.S. commercialization of hemodiafiltration-capable systems introduce a premium therapy platform that combines machines, dialyzers, bloodlines, substitution-fluid generation, disinfection workflows, and clinical data integration. Even gradual penetration could materially increase market value because adoption requires both capital replacement and recurring specialty consumables.

A sixth driver is the chronic workforce shortage in nephrology nursing and dialysis technical roles. Labor availability constrains new clinic capacity, increases overtime, and raises the economic cost of complex equipment. Procurement committees therefore prioritize intuitive interfaces, automated priming, integrated disinfection, fewer nuisance alarms, remote service, faster turnover, and standardized training. In home care, the same logic applies to patient usability and caregiver burden. Devices that shift work away from scarce clinical staff or make training more repeatable can gain share without competing solely on unit price.

A seventh driver is the need to reduce vascular-access complications and hospitalization. Nearly four in five patients starting hemodialysis still begin with a catheter, despite the infection and utilization risks associated with catheter-dependent care. This sustains demand for tunneled dialysis catheters, guidewires, antimicrobial technologies, fistula needles, access surveillance, thrombectomy and declotting products, and devices used to create or maintain arteriovenous access. Vascular access is commercially attractive because it connects chronic dialysis demand with procedural care in hospitals, ambulatory centers, and office-based vascular laboratories.

An eighth driver is supply-chain resilience. Dialysis is highly sensitive to disruption because treatment cannot be deferred for long. Providers increasingly evaluate dual sourcing, domestic inventory, regional distribution, disaster readiness, water availability, and continuity plans. The operational shocks created by hurricanes, plant outages, logistics delays, and product recalls have elevated supply reliability to an executive procurement issue. Manufacturers with diversified production, strong field service, and transparent inventory systems can defend contracts even when their products are not the lowest-priced option.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. dialysis device market is increasingly focused on treatment flexibility, convective clearance, automation, water independence, patient usability, cybersecurity, and longitudinal data. The next competitive cycle will not be won by a machine that performs filtration alone. It will be won by platforms that reduce the operational burden of delivering safe dialysis across multiple settings while producing better evidence on treatment quality and total cost.

High-volume hemodiafiltration is one of the most important emerging innovations. Fresenius Medical Care received updated FDA clearance in 2025 for its 5008X CAREsystem and began a phased U.S. rollout ahead of broader commercialization in 2026. The system brings online generation of substitution fluid and a therapy approach already used in many international markets. For U.S. providers, the commercial decision will depend on clinical outcomes, workflow fit, water and disinfection requirements, reimbursement economics, and the ability to standardize the therapy across large networks. If adoption expands, it will stimulate replacement demand for machines and pull through specialty dialyzers and bloodline sets.

Compact and all-in-one hemodialysis platforms are another major innovation area. Systems that integrate water purification, dialysate production, connectivity, and treatment controls can reduce dependence on centralized water loops and fixed dialysis rooms. This is especially relevant for hospitals seeking enterprise-wide acute dialysis capability and for home programs that need simplified installation. Next-generation platforms are also being designed around current cybersecurity expectations, enterprise network compatibility, and remote software management. These functions are becoming procurement requirements as dialysis machines increasingly behave like connected clinical endpoints rather than isolated equipment.

Peritoneal dialysis innovation is concentrated in smaller cyclers, automated prescription delivery, remote patient management, cloud-connected treatment records, and improved transfer-set safety. The clinical challenge in PD is not only initiating patients; it is maintaining them successfully at home. Platforms that help clinicians detect missed treatments, drain problems, fluid imbalance, or adherence changes can improve intervention timing. Better packaging and lower-volume solutions may also reduce storage burden, a practical barrier for patients living in small homes or apartments.

Continuous kidney replacement therapy is evolving through more precise fluid management, simplified cartridge loading, improved anticoagulation workflows, and integration with broader critical-care monitoring. In pediatric and sepsis-associated acute kidney injury, emerging extracorporeal devices are extending the concept of renal support beyond solute clearance toward immune-cell modulation and organ-support strategies. These products remain specialized, but they demonstrate that the acute renal device market is moving toward condition-specific platforms rather than one standardized filtration approach.

Membrane engineering remains a core source of differentiation. High-flux synthetic membranes, medium cut-off concepts, improved biocompatibility, endotoxin control, albumin preservation, and selective adsorption are being used to target a wider range of uremic toxins. The commercial value of membrane innovation is amplified by recurring use: even a modest premium per dialyzer can generate substantial annual revenue across a large treatment base. However, providers will demand evidence that premium membranes improve outcomes, reduce symptoms, or enable a differentiated therapy rather than simply increasing consumable cost.

Artificial intelligence and predictive analytics are emerging as a strategic layer. Potential applications include ultrafiltration guidance, treatment-risk alerts, access-failure prediction, hospitalization risk stratification, inventory forecasting, and identification of patients likely to succeed with home modalities. Adoption will depend on data quality, clinical validation, interoperability, workflow integration, and clear accountability. The near-term opportunity is decision support that makes nurses and nephrologists more efficient, not autonomous treatment control.

Manufacturers are also raising the bar through evidence generation and service design. Large providers increasingly expect real-world treatment data, implementation support, staff training, health-economic models, disaster-response planning, and measurable uptime commitments. For a new dialysis platform, commercial success requires more than FDA clearance. The vendor must help the customer redesign workflow, manage consumables, train staff or patients, maintain treatment continuity, and justify the economics under bundled reimbursement.

 

Segmentation Insights

The U.S. Dialysis Devices Market is segmented on the basis of product category, modality, application, end user, and technology type.

 

By Product Category

Hemodialysis Machines and Systems

Hemodialysis machines and systems form the largest capital-equipment category. The installed base spans freestanding clinics, hospitals, skilled nursing environments, and home programs. Replacement demand is driven by age, maintenance cost, software support, treatment capability, and network standardization. Conventional machines retain a large base because providers value familiarity and service coverage, while new systems gain share where they reduce infrastructure, automate setup, support hemodiafiltration, or operate across acute and chronic settings. Revenue growth will exceed unit growth as next-generation systems carry higher digital and therapy value.

Dialyzers and Hemofilters

Dialyzers and hemofilters represent one of the most important recurring-revenue segments. The U.S. treatment base consumes a large volume of high-flux dialyzers, CRRT filters, hemofilters, and specialized membranes every year. Product selection is influenced by clearance performance, membrane material, surface area, biocompatibility, albumin retention, therapy compatibility, and contract pricing. The segment benefits directly from treatment volume and is positioned for premiumization as hemodiafiltration, medium cut-off membranes, and targeted adsorption technologies expand.

Bloodlines, Tubing Sets, Needles, and Treatment Disposables

Blood tubing sets, fistula needles, syringes, connectors, clamps, cartridges, and treatment kits create a dense consumable stream tied to every dialysis session. Providers prioritize compatibility, ease of setup, packaging efficiency, safety features, and supply reliability. Standardized treatment kits can reduce picking time and inventory complexity, making them attractive to large networks. Growth is supported by rising treatment intensity, acute-care utilization, and the shift toward integrated proprietary disposables paired with specific machines.

Dialysate Delivery, Concentrates, and Water-Treatment Systems

Dialysate concentrates, bicarbonate systems, reverse-osmosis units, endotoxin-retentive filters, disinfection equipment, central distribution loops, and point-of-use purification are essential to dialysis operations. The segment is receiving renewed attention because water quality, infrastructure cost, and emergency resilience affect treatment continuity. Integrated water generation within compact systems can reduce fixed infrastructure in hospitals and homes, while large clinics continue to require efficient central systems. Sustainability considerations, including water and chemical use, will increasingly influence procurement.

Peritoneal Dialysis Devices and Consumables

Peritoneal dialysis devices include automated cyclers, CAPD transfer systems, tubing sets, connectors, drainage bags, warming equipment, and daily dialysate solutions. Consumables account for most category revenue because PD is performed every day. Growth is supported by the increasing share of incident patients selecting PD, patient demand for home-based care, and provider interest in lower treatment cost compared with in-center hemodialysis. Commercial performance depends on supply delivery, remote monitoring, training support, and the ability to reduce peritonitis and technique failure.

Continuous Kidney Replacement and Acute Dialysis Systems

Continuous kidney replacement therapy and acute dialysis systems serve ICUs, cardiac surgery, transplant, sepsis, oncology, and emergency care. This segment includes machines, hemofilters, tubing sets, anticoagulation components, replacement fluids, and specialty cartridges. It has a smaller patient base than chronic dialysis but high value per treated episode. Demand is supported by severe acute kidney injury, complex surgery, and hospital strategies to internalize or standardize renal support. Premium systems compete on fluid precision, ease of use, cartridge setup, alarm management, and compatibility with critical-care workflows.

Vascular Access Devices

Vascular access devices include tunneled and non-tunneled dialysis catheters, fistula needles, graft-related products, guidewires, introducers, antimicrobial technologies, and access-maintenance devices. The segment remains essential because a large share of patients initiate hemodialysis with a catheter and many require repeated interventions to maintain access patency. Demand is linked to dialysis initiation, access complications, thrombosis, infection prevention, and growth of outpatient vascular access centers. Products that reduce infection, improve flow, or simplify placement can command premium positioning.

 

By Modality

In-Center Hemodialysis

In-center hemodialysis remains the dominant modality and accounts for the largest share of device revenue. Its scale is supported by a mature network of clinics, established staffing models, and the clinical needs of patients who require supervised treatment. The segment generates recurring demand for machines, dialyzers, bloodlines, needles, concentrates, water systems, and maintenance services. Growth will be moderate in patient terms but stronger in value as providers adopt new machines, advanced membranes, hemodiafiltration, and connected workflow systems.

Home Hemodialysis

Home hemodialysis is a smaller but strategically important modality. It offers schedule flexibility and may support more frequent treatment, but adoption is constrained by training, caregiver availability, home infrastructure, fear of self-cannulation, and program attrition. The best-positioned platforms simplify installation, reduce treatment steps, support remote clinical oversight, and offer dependable consumable delivery. Market growth will be driven by selected high-performing programs rather than uniform national adoption.

Peritoneal Dialysis

Peritoneal dialysis is the largest home-dialysis modality and one of the clearest recurring-consumable opportunities. Automated PD cyclers dominate many U.S. home programs, while CAPD remains relevant for patients who prefer manual exchanges or require backup flexibility. The all-time-high incident PD start share in 2023 indicates improving patient selection and modality education. Future growth depends on infection prevention, remote treatment visibility, smaller equipment, lower storage burden, and earlier placement of PD catheters.

Acute Intermittent Dialysis, SLED, and Continuous Therapy

Acute renal replacement includes intermittent hemodialysis, sustained low-efficiency dialysis, and continuous therapy. Hospitals choose among these modalities based on hemodynamic stability, ICU staffing, fluid-management requirements, and equipment availability. The segment creates opportunities for flexible platforms that can cover multiple prescriptions, as well as specialized continuous systems with precise fluid balance. Consumable intensity and urgent replacement requirements make supplier reliability particularly important.

 

By Application

Chronic End-Stage Kidney Disease

Chronic kidney failure is the primary application and provides the market’s most predictable demand. Patients receiving maintenance dialysis require long-term, repetitive treatment, often for years. The application supports nearly every major product category, from capital equipment and water systems to daily or per-treatment disposables. Commercial growth is driven by the size of the prevalent dialysis population, survival, modality mix, and replacement of installed equipment rather than large swings in annual incidence.

Acute Kidney Injury

Acute kidney injury is the fastest-growing hospital application because it is associated with sepsis, major surgery, shock, trauma, cardiac procedures, and complex medication exposure. Patients may require temporary intermittent dialysis or continuous therapy until kidney function recovers. Hospitals value systems that can be rapidly deployed, used by available staff, and integrated into ICU fluid-management protocols. This application also supports innovation in organ-support cartridges and condition-specific extracorporeal therapies.

Critical-Care and Multi-Organ Support

Critical-care applications extend beyond isolated renal failure. Renal replacement is often delivered alongside ventilation, vasopressor support, extracorporeal life support, or advanced cardiac care. These cases require precise fluid removal, stable anticoagulation, and close monitoring. Devices that reduce circuit downtime, support data integration, and function reliably in crowded ICU environments are favored. The segment has high clinical acuity and premium pricing but also requires strong training and field support.

Pediatric and Specialty Renal Support

Pediatric dialysis, sepsis-associated AKI, intoxication management, and selected liver-support or inflammatory conditions form smaller specialty applications. They are clinically demanding because treatment prescriptions must account for body size, vascular access limitations, and rapid physiological changes. Specialized filters, low-volume circuits, and condition-specific cartridges can create high-value niches. Regulatory pathways and evidence requirements are more complex, but successful products can benefit from limited competition.

 

By End User

Freestanding Dialysis Centers and Large Provider Networks

Freestanding dialysis centers are the largest end users and exert substantial purchasing power. Large networks standardize machines, disposables, and water systems across hundreds or thousands of sites, negotiate multi-year contracts, and evaluate suppliers on total treatment cost and continuity. Vendor access depends on clinical evidence, national service coverage, inventory reliability, training capability, and compatibility with established workflows. A technology may be clinically attractive but fail commercially if implementation would disrupt staffing or supply-chain standardization.

Hospitals and Integrated Health Systems

Hospitals purchase intermittent hemodialysis and continuous therapy systems for ICUs, emergency care, surgery, oncology, and transplant programs. Health systems increasingly compare outsourced and insourced dialysis models. Compact systems that reduce water infrastructure and allow broader nurse deployment can change the economics of acute dialysis. Enterprise buyers also require cybersecurity, interoperability, maintenance responsiveness, and standardized training across multiple campuses.

Home Care Programs and Patients

Home users include patients receiving automated PD, CAPD, and home hemodialysis. The purchasing decision is usually made by a provider, but patient experience determines program retention and consumable utilization. Equipment must be intuitive, safe, compact, and supported by reliable logistics. Remote treatment visibility, multilingual education, responsive technical support, and simplified troubleshooting are essential commercial capabilities. Vendors that reduce technique failure can create value for both providers and patients.

Academic Medical Centers and Specialty Kidney Programs

Academic centers and specialty programs are important early adopters of hemodiafiltration, advanced membranes, pediatric renal support, and novel acute-care devices. These institutions generate clinical evidence, train nephrologists and nurses, and influence broader adoption. Procurement is rigorous and often requires protocol development, information-security review, and health-economic justification. Success in these centers can establish clinical credibility but does not automatically translate into community adoption without a scalable service model.

Government, Veterans, and Public-Sector Providers

Veterans Health Administration facilities, military hospitals, public hospitals, and correctional or safety-net systems represent a distinct procurement channel. These buyers emphasize contract compliance, long-term service, domestic distribution, training, and continuity across geographically dispersed sites. Public-sector demand is particularly relevant for home dialysis access, rural care, and disaster preparedness. Sales cycles may be longer, but awarded contracts can provide stable volume.

 

By Technology Type

Conventional High-Flux Hemodialysis

Conventional high-flux hemodialysis remains the largest technology type. It is deeply embedded in U.S. treatment protocols, staff training, facility infrastructure, and reimbursement. Growth is steady rather than disruptive, with value driven by machine replacement, membrane upgrades, and operational efficiency. Vendors with broad service networks and compatible consumable portfolios retain an advantage because providers prioritize treatment continuity over rapid technology switching.

Online Hemodiafiltration

Online hemodiafiltration is expected to be the fastest-growing premium technology through 2035. The U.S. market is at the beginning of a commercialization cycle, creating opportunities in systems, dialyzers, bloodlines, substitution-fluid generation, and clinical support. Adoption will initially concentrate in sophisticated provider networks and centers able to manage implementation. Long-term penetration depends on outcomes evidence, reimbursement fit, staff acceptance, and the cost of replacing existing machines.

Portable, Compact, and Integrated-Water Systems

Portable and compact platforms address hospital mobility, home installation, and infrastructure constraints. Integrated-water systems can eliminate the need for extensive plumbing and central water loops in selected settings. Their value proposition is strongest when they reduce installation cost, simplify deployment, and allow equipment to move across units. The category will expand as hospitals pursue flexible acute dialysis capacity and home programs seek easier installation, although reliability and consumable economics remain decisive.

Automated Peritoneal Dialysis and Remote Patient Management

Automated PD combines cyclers with software, prescription management, and remote treatment review. This technology is important because home-dialysis success depends on visibility outside the clinic. Platforms that transmit treatment data can help care teams identify adherence problems, ultrafiltration changes, and technical issues earlier. The market will move toward more integrated digital ecosystems, but vendors must demonstrate data security, interoperability, and manageable alert burden.

Connected and Predictive Dialysis Platforms

Connected dialysis platforms integrate machines, electronic records, service diagnostics, inventory data, and predictive decision support. The near-term commercial benefit is workflow automation: reducing manual documentation, improving device uptime, and standardizing treatment records. Over time, analytics may support personalized ultrafiltration, access-risk prediction, and home-modality management. Cybersecurity clearance and enterprise IT compatibility will increasingly affect product selection, particularly in large hospital systems.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Dialysis Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand differs based on population size, CKD burden, diabetes prevalence, age distribution, dialysis-facility density, rural access, hospital infrastructure, provider consolidation, home-modality adoption, and exposure to natural disasters. The South is the largest regional market, while the West is expected to record the fastest growth through 2035. The Northeast is the most clinically sophisticated on a per-site basis, and the Midwest provides a stable base of in-center dialysis, hospital renal support, and medtech manufacturing expertise.

South

The South is the dominant regional market, accounting for an estimated USD 3.18 billion in 2025. It includes Texas, Florida, Georgia, North Carolina, Virginia, Maryland, Tennessee, South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, Oklahoma, Delaware, and the District of Columbia. The region combines the largest population growth with a high prevalence of diabetes, obesity, hypertension, and diagnosed CKD. County-level analyses show particularly elevated CKD burden in Florida and the Appalachian corridor extending through parts of Pennsylvania, Ohio, West Virginia, Kentucky, Tennessee, and Alabama. These factors support strong demand for chronic dialysis equipment, vascular-access devices, home PD supplies, and hospital acute-care systems.

Texas is the most important state market in the region because of its population scale, rapid growth, large metropolitan health systems, and significant diabetes burden. Houston, Dallas-Fort Worth, San Antonio, and Austin support high treatment volumes across freestanding clinics and hospitals. Texas also has broad rural geography, creating a practical need for distributed dialysis capacity, remote oversight, and dependable supply delivery. Manufacturers can pursue both premium integrated systems in large health systems and cost-efficient machines and disposables across community networks.

Florida is a major dialysis market because of its large older population, high CKD prevalence, and substantial Medicare exposure. Demand is concentrated in Miami, Tampa, Orlando, Jacksonville, and retirement-heavy coastal markets, but the state also faces hurricane-related treatment-continuity risk. This increases the value of emergency preparedness, backup power planning, portable systems, home supply continuity, and regional inventory. Florida is especially attractive for automated PD, chronic hemodialysis disposables, and vascular-access products because older patients often have complex comorbidities and repeated hospitalization risk.

Georgia, North Carolina, Virginia, and Tennessee are high-growth device markets. Atlanta, Charlotte, Raleigh-Durham, Richmond, Norfolk, Nashville, and Memphis have expanding health systems and specialty-care capacity. North Carolina and Georgia benefit from sustained population growth, while Tennessee has strong regional referral centers and high chronic-disease burden. Virginia and Maryland combine large integrated systems, federal healthcare activity, and sophisticated hospital procurement. These states offer opportunities for acute dialysis insourcing, connected equipment, and enterprise contracts.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, and Oklahoma have smaller populations but disproportionate kidney disease burden. Rural access limitations and workforce shortages make conventional clinic expansion difficult in some areas. The commercial opportunity therefore has two layers: recurring in-center demand in regional hubs and scalable home or remote-management solutions for dispersed patients. Vascular-access devices are also important because delayed nephrology referral and late dialysis initiation can increase catheter use.

The South is expected to grow at an estimated CAGR of 9.10% and reach approximately USD 7.60 billion by 2035. Growth will be driven by population migration, high diabetes prevalence, clinic replacement cycles, expansion of home programs, hospital demand for flexible acute dialysis, and increased use of premium dialyzers and connected systems. The region will remain the largest market, but competition will be intense because national provider networks have strong purchasing leverage.

West

The West represented an estimated USD 2.02 billion in 2025 and is expected to be the fastest-growing region, with an estimated CAGR of 9.45% through 2035. It includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. The region combines large population centers, rapid growth in several states, advanced digital-health adoption, strong medtech innovation, and significant geographic variation in access. It also includes non-contiguous markets where dialysis delivery costs are structurally higher; CMS introduced additional 2026 payment adjustments for Alaska and Hawaii to reflect elevated non-labor costs.

California is the largest state market in the West and one of the most important dialysis device markets nationally. Its population exceeds 39 million, and the state contains major academic systems, large dialysis networks, safety-net providers, and a strong medical technology ecosystem. California is an early market for connected machines, home platforms, digital renal care, and clinical trials. Los Angeles, the Bay Area, San Diego, Sacramento, and the Central Valley have different payer mixes and disease burdens, requiring manufacturers to support both premium innovation and high-volume cost efficiency.

Arizona and Nevada are fast-growing demand centers because of population migration and aging demographics. Phoenix, Tucson, Las Vegas, and Reno are expanding healthcare markets with increasing need for chronic dialysis stations, home therapies, and acute hospital capability. Water scarcity creates an additional strategic consideration. Technologies that reduce water consumption or simplify purification may gain greater attention, particularly as sustainability and utility costs enter capital review processes.

Washington and Oregon are attractive for home dialysis, integrated-care models, and connected treatment platforms. Large health systems in Seattle, Portland, and surrounding areas tend to evaluate technology through enterprise IT, quality, and population-health frameworks. The Pacific Northwest also has a history of kidney-care innovation and nonprofit dialysis delivery. This supports early evaluation of systems that improve patient autonomy or reduce infrastructure dependence.

Colorado and Utah have growing metropolitan populations, strong integrated delivery networks, and advanced specialty programs. Denver and Salt Lake City serve large referral geographies, creating demand for both high-acuity hospital renal support and home programs that reduce travel. New Mexico, Idaho, Montana, and Wyoming have dispersed populations and rural access constraints. In these states, service coverage, remote monitoring, and logistics can be more important than a marginal equipment-price difference.

Alaska and Hawaii are small in absolute volume but strategically distinctive. Shipping costs, limited local inventory, geographic isolation, and disaster exposure increase the importance of supply continuity. CMS payment adjustments recognize the higher non-labor cost of dialysis in these locations. Vendors with robust remote service, regional stock, and compact equipment can create disproportionate value. By 2035, the West is expected to reach approximately USD 4.98 billion, supported by connected systems, home adoption, hospital modernization, and high-value technology mix.

Northeast

The Northeast accounted for an estimated USD 1.78 billion in 2025. It includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, New Hampshire, Vermont, and Maine. The region is mature in facility coverage but high in clinical complexity, academic concentration, and technology intensity. Large teaching hospitals, transplant centers, and integrated health systems create a favorable environment for hemodiafiltration, advanced acute dialysis, pediatric renal support, and data-connected platforms.

New York is the largest state market in the Northeast. New York City and Long Island support dense dialysis utilization, while upstate regions require broader geographic coverage and community networks. Space constraints in urban facilities increase the value of compact equipment and efficient supply storage. Academic centers in New York also influence adoption of specialty filters, advanced CRRT, and new treatment protocols. Procurement is evidence-driven and often involves extensive cybersecurity and integration review.

Pennsylvania and New Jersey provide large chronic dialysis and hospital markets. Pennsylvania combines Philadelphia and Pittsburgh academic systems with Appalachian counties that carry high CKD burden. New Jersey has high population density, substantial Medicare and commercial coverage, and access to major regional provider networks. Both states are attractive for vascular-access products, clinic replacement programs, and home PD expansion.

Massachusetts is smaller by population but highly influential because of its academic hospitals, biotechnology ecosystem, and clinical-research infrastructure. Boston-based institutions can act as early evaluators of hemodiafiltration, connected treatment systems, and specialty acute-care devices. Connecticut and Rhode Island have mature provider markets with strong health-system purchasing. Maine, Vermont, and New Hampshire are smaller but important for rural service models and home-dialysis logistics.

The Northeast is expected to grow at an estimated CAGR of 8.20% and reach approximately USD 3.91 billion by 2035. Growth will be slower than in the South and West because population expansion is more limited and the installed base is mature. However, the region should remain attractive on a value-per-site basis because of premium technology adoption, complex hospital care, and a high concentration of clinical decision-makers.

Midwest

The Midwest represented an estimated USD 1.67 billion in 2025 and is expected to show steady, durable growth. It includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota. The region combines large urban health systems, established dialysis networks, high chronic-disease prevalence in several states, rural referral patterns, and an important medical-device manufacturing base.

Illinois, Ohio, Michigan, and Minnesota are the major state markets. Chicago supports a large network of academic, community, and safety-net providers. Ohio has strong kidney and cardiovascular care infrastructure in Cleveland, Columbus, and Cincinnati, while parts of the state overlap with the Appalachian CKD burden corridor. Michigan has substantial demand for chronic dialysis and hospital renal support in Detroit, Grand Rapids, and regional centers. Minnesota is strategically important because of its medtech ecosystem, engineering talent, and sophisticated provider systems.

Indiana, Wisconsin, and Missouri provide stable demand for machines, dialyzers, water systems, and vascular access. Indianapolis, Milwaukee, Madison, St. Louis, and Kansas City function as regional referral hubs. These markets often emphasize standardized contracting, service reliability, and demonstrable operating savings. They can be attractive launch sites after a new platform has established evidence in coastal academic centers because health systems are large enough to scale but disciplined in capital review.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller but important for rural dialysis access. Patients may travel long distances to treatment, and winter weather can disrupt care. Home modalities, tele-nephrology support, remote monitoring, and regional inventory can improve resilience. Hospitals in these states also require acute dialysis capability despite lower case volume, favoring flexible equipment that can support multiple treatment types without extensive dedicated infrastructure.

The Midwest is expected to expand at an estimated CAGR of 7.70% and reach approximately USD 3.51 billion by 2035. Growth will be supported by replacement of aging equipment, hospital standardization, selective home expansion, high chronic disease burden, and recurring consumable demand. The region is less likely to lead initial premium adoption, but it offers reliable scale once technologies demonstrate clinical and economic value.

 

Key Market Players

The U.S. Dialysis Devices Competitive Landscape is concentrated in core hemodialysis and peritoneal dialysis platforms, while remaining fragmented across vascular access, water treatment, specialty membranes, acute renal support, and emerging connected systems. Fresenius Medical Care and Vantive hold broad positions across equipment and consumables. A second group of global manufacturers competes in machines, dialyzers, CRRT, access products, and water systems. Emerging U.S. and international innovators are creating new competition in integrated-water hemodialysis, flexible professional-care systems, home platforms, digital connectivity, and specialty AKI devices.

Competition is increasingly ecosystem-based. Large suppliers can bundle machines, dialyzers, bloodlines, concentrates, service, software, training, and logistics. New entrants can gain traction when they solve a specific workflow problem, such as eliminating fixed water infrastructure, improving mobility, simplifying setup, or enabling a new therapy. However, scaling in the U.S. requires field service, reimbursement understanding, consumable supply, regulatory maintenance, cybersecurity capability, and access to concentrated provider networks.

• Fresenius Medical Care,
• Vantive,
• B. Braun Medical,
• Nipro Medical Corporation,
• Nikkiso America,
• Outset Medical,
• Quanta Dialysis Technologies,
• Diality,
• DEKA Research & Development,
• Asahi Kasei Medical,
• Toray Medical,
• JMS North America,
• Medtronic,
• Becton, Dickinson and Company,
• AngioDynamics,
• Teleflex,
• Merit Medical Systems,
• Cook Medical,
• Medical Components, Inc. (Medcomp),
• Nephros,
• Rockwell Medical,
• Mar Cor Purification,
• SeaStar Medical,
• Medline Industries,

Fresenius Medical Care is the most vertically integrated competitor, combining a large U.S. treatment network with machines, dialyzers, bloodlines, water systems, and an expanding hemodiafiltration platform. Vantive, established as an independent kidney-care company following the 2025 divestiture of Baxter Kidney Care, has deep positions in peritoneal dialysis, hemodialysis, continuous therapy, solutions, and digital support. Their scale gives them purchasing insight, service reach, and recurring-consumable leverage that smaller competitors must offset through differentiated technology.

Outset Medical, Quanta Dialysis Technologies, Diality, and DEKA represent the strategic shift toward compact, flexible, and simplified hemodialysis systems. Outset has established an integrated-water platform used across hospital and home environments and received 2026 clearance for a next-generation cybersecurity architecture. Diality secured FDA clearance for professional use of its Moda-flx system in 2024 and is pursuing home use. Quanta is positioned around compact high-performance dialysis, while DEKA has contributed significant engineering innovation to home hemodialysis.

B. Braun, Nipro, Nikkiso, Asahi Kasei, Toray, and JMS compete through global renal technology, membrane, tubing, and consumable portfolios. BD, AngioDynamics, Teleflex, Merit Medical, Cook Medical, and Medcomp are important in vascular access and related intervention. Nephros and Mar Cor participate in water purification and fluid quality, while Rockwell Medical supplies dialysis concentrates. SeaStar Medical is developing a specialty acute kidney injury franchise around selective cytopheretic technology. Medline supports a broad supply and distribution role across dialysis and hospital consumables.

Market share through 2035 will be influenced by provider contracts, machine replacement cycles, successful U.S. adoption of hemodiafiltration, home-program retention, acute-care insourcing, cybersecurity, FDA clearances, service coverage, and supply continuity. Companies that demonstrate lower total treatment cost, faster staff training, reduced water or infrastructure requirements, fewer interruptions, and strong recurring-consumable reliability will be best positioned to defend premium pricing.

 

Recent Developments

Recent developments in the U.S. Dialysis Devices Market show a clear shift toward higher-performance therapy, connected machines, and new corporate structures. In 2025, Fresenius Medical Care received updated FDA clearance for the hemodiafiltration-capable 5008X CAREsystem and began deploying the platform in selected U.S. clinics. A broader commercial launch in 2026 introduces a new equipment replacement cycle and may establish online high-volume hemodiafiltration as a premium U.S. therapy category.

The competitive structure changed in January 2025 when Baxter completed the sale of its Kidney Care business, which became Vantive. The transaction created an independent company focused on kidney care and vital-organ support. For customers, the separation increases strategic focus on peritoneal dialysis, hemodialysis, continuous therapy, digital solutions, and supply resilience. It also changes the competitive comparison from a diversified hospital-products company to a dedicated renal platform.

Diality received FDA 510(k) clearance in 2024 for the Moda-flx Hemodialysis System in professional-care settings and subsequently advanced a home-use clinical program. This development is important because it adds another challenger to a machine market historically dominated by a small number of suppliers. Commercial success will depend on manufacturing scale, service infrastructure, consumable economics, and the ability to convert provider interest into network-level deployment.

Outset Medical resolved an FDA warning-letter matter in 2025 and received FDA clearance in January 2026 for a next-generation Tablo platform designed around enterprise cybersecurity, reliability, and connectivity. The system is expected to support hospitals, health systems, and home providers. Cybersecurity is becoming a differentiated procurement factor because connected dialysis systems interact with hospital networks, cloud services, treatment records, and remote support environments.

In acute kidney injury, SeaStar Medical continued the commercial introduction of QUELIMMUNE after its 2024 FDA humanitarian device approval for pediatric patients with life-threatening AKI associated with sepsis or a septic condition who require renal replacement therapy. The product illustrates the movement toward specialty cartridges used alongside conventional continuous therapy. Adult studies may expand the addressable acute renal support opportunity if safety, efficacy, and reimbursement are established.

The reimbursement environment also changed. CMS increased the 2026 ESRD PPS base rate to USD 281.71 and projected USD 6.0 billion in Medicare payments to approximately 7,600 facilities. CMS also finalized early termination of the ESRD Treatment Choices Model at the end of 2025 after the model did not deliver the expected quality and savings results. Home dialysis growth will therefore depend more heavily on provider economics, patient selection, technology usability, and local program execution rather than a single national payment experiment.

Supply resilience remains a strategic development area. Disruptions affecting saline, solutions, manufacturing plants, and regional logistics have reinforced the need for redundant supply, emergency inventory, and disaster planning. Dialysis providers are increasingly incorporating continuity metrics into vendor selection, particularly in hurricane-prone Southern states, isolated Western markets, and rural regions where alternative treatment capacity is limited.

 

Conclusion

The U.S. Dialysis Devices Market Size & Share is positioned for sustained expansion from USD 8.65 billion in 2025 to approximately USD 20.03 billion by 2035, supported by an 8.76% CAGR during the forecast period. The market’s long-term strength is grounded in the large CKD population, a record kidney failure burden, recurring treatment requirements, Medicare-backed reimbursement, and the combination of capital equipment with high-frequency consumables.

The most attractive growth opportunities will come from online hemodiafiltration, compact and integrated-water hemodialysis systems, automated peritoneal dialysis, remote patient management, connected machines, advanced dialyzers, acute kidney injury platforms, and vascular-access technologies. Conventional in-center hemodialysis will remain the largest modality, but value growth will increasingly depend on technologies that improve workflow, reduce infrastructure, address labor constraints, and support care outside fixed dialysis clinics.

Regional opportunity will be led by the South because of population growth and kidney disease burden, followed by the West because of technology adoption and expanding metropolitan markets. The Northeast will remain important for premium clinical innovation and early evidence generation, while the Midwest will provide stable replacement and consumable demand. Texas, Florida, California, New York, Pennsylvania, Illinois, Ohio, Georgia, North Carolina, Arizona, Michigan, and Massachusetts will remain especially important state markets.

For clients evaluating this industry, the central question is not whether dialysis demand will persist. The more important questions are which modality gains share, how rapidly U.S. providers adopt hemodiafiltration and integrated-water systems, whether home programs can improve retention, and how concentrated provider purchasing shapes market access. Companies that combine differentiated therapy, dependable consumable supply, field service, digital integration, and credible treatment economics will define the next decade of the U.S. dialysis devices industry.

 

TABLE OF CONTENT

1. U.S. Dialysis Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Dialysis Device and Renal-Care Technology Manufacturers
1.6.2. Membrane, Component, Contract Manufacturing, and Consumable Suppliers
1.6.3. Freestanding Dialysis Centers and Large Provider Networks
1.6.4. Hospitals, Integrated Health Systems, and Critical-Care Units
1.6.5. Home Dialysis Programs, Patients, and Caregivers
1.6.6. Group Purchasing Organizations, Distributors, and Specialty Renal Suppliers
1.6.7. CMS, FDA, Payers, Nephrologists, and Clinical Decision-Makers
What this section provides: This section defines the device-market boundary, study scope, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. dialysis devices market is measured, segmented, and validated.

2. U.S. Dialysis Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
What this section provides: This section gives decision-makers a concise view of market size, growth direction, modality shifts, recurring-consumable economics, competitive intensity, and priority investment opportunities.

3. U.S. Dialysis Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Chronic Kidney Disease and Kidney Failure Burden
3.1.2. Recurring Treatment Frequency and Consumable Utilization
3.1.3. Expansion of Home Hemodialysis and Peritoneal Dialysis
3.1.4. Growth in Acute Kidney Injury and Critical-Care Renal Support
3.1.5. Dialysis Machine Replacement and Connected-System Modernization
3.1.6. Medicare ESRD Coverage and Predictable Treatment Reimbursement
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital, Water-Treatment, and Facility Infrastructure Costs
3.2.2. Bundled Reimbursement Pressure and Provider Margin Constraints
3.2.3. Nephrology Nurse, Technician, and Patient-Training Constraints
3.2.4. Infection, Vascular Access, Product Recall, and Treatment-Safety Risks
3.2.5. Home Dialysis Attrition and Patient Suitability Limitations
3.3. Opportunities and Their Impact Analysis
3.3.1. Online High-Volume Hemodiafiltration Adoption
3.3.2. Compact and Integrated-Water Hemodialysis Platforms
3.3.3. Automated Peritoneal Dialysis and Remote Patient Management
3.3.4. Specialty Acute Kidney Injury Filters and Therapeutic Cartridges
3.3.5. Rural, Mobile, Skilled-Nursing, and Distributed Dialysis Models
3.3.6. Predictive Analytics, Cybersecurity, and Renal Data Integration
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Dialysis Clinical Workflow Economics Analysis
3.7. Hospital and Provider Capital Procurement Behavior Analysis
What this section provides: This section explains the clinical, reimbursement, operational, and commercial forces shaping device demand, helping clients evaluate growth opportunities, adoption barriers, and execution risks.

4. U.S. Dialysis Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization and Connected Renal Care
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS ESRD Reimbursement and Coverage Landscape
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Kidney Health Programs
4.11. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.12. Dialysis Provider and Hospital Value Analysis Decision Framework
What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply continuity, digital adoption, water infrastructure, and procurement dynamics.

5. U.S. Dialysis Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Hemodialysis Machines and Systems
5.1.3. Dialyzers and Hemofilters
5.1.4. Bloodlines, Tubing Sets, Needles, and Treatment Disposables
5.1.5. Dialysate Delivery, Concentrates, and Water-Treatment Systems
5.1.6. Peritoneal Dialysis Devices and Consumables
5.1.7. Continuous Kidney Replacement and Acute Dialysis Systems
5.1.8. Vascular Access Devices
What this section provides: This section identifies which dialysis device and consumable categories are expected to generate the largest revenue contribution, strongest recurring demand, and highest growth through 2035.

6. U.S. Dialysis Devices Market – By Modality

6.1. Overview
6.1.1. Segment Share Analysis, By Modality, 2025 & 2035 (%)
6.1.2. In-Center Hemodialysis
6.1.3. Home Hemodialysis
6.1.4. Peritoneal Dialysis
6.1.5. Acute Intermittent Dialysis, SLED, and Continuous Kidney Replacement Therapy
What this section provides: This section evaluates device demand by renal replacement modality and helps clients compare the installed-base strength of in-center care with growth opportunities in home and acute dialysis.

7. U.S. Dialysis Devices Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Chronic End-Stage Kidney Disease
7.1.3. Acute Kidney Injury
7.1.4. Critical-Care and Multi-Organ Support
7.1.5. Pediatric and Specialty Renal Support
What this section provides: This section helps clients understand demand by clinical use case and prioritize applications with high treatment intensity, specialized device requirements, and attractive consumable economics.

8. U.S. Dialysis Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Freestanding Dialysis Centers and Large Provider Networks
8.1.3. Hospitals and Integrated Health Systems
8.1.4. Home Care Programs and Patients
8.1.5. Academic Medical Centers and Specialty Kidney Programs
8.1.6. Government, Veterans, and Public-Sector Providers
What this section provides: This section explains which care settings and customer groups drive dialysis equipment purchasing, recurring supply utilization, capital replacement, and adoption of advanced renal-support technologies.

9. U.S. Dialysis Devices Market – By Technology Type

9.1. Overview
9.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
9.1.2. Conventional High-Flux Hemodialysis
9.1.3. Online Hemodiafiltration
9.1.4. Portable, Compact, and Integrated-Water Systems
9.1.5. Automated Peritoneal Dialysis and Remote Patient Management
9.1.6. Connected and Predictive Dialysis Platforms
What this section provides: This section evaluates the technologies reshaping renal replacement therapy, including high-flux dialysis, hemodiafiltration, compact systems, automated home therapy, connectivity, and predictive workflows.

10. U.S. Dialysis Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Dialysis Population, Facility Footprint, and Installed-Base Analysis
10.1.4. Regional Reimbursement, Home-Modality, and Procurement Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Dialysis Device Key Manufacturers, Provider Networks, and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Dialysis Device Key Manufacturers, Provider Networks, and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Dialysis Device Key Manufacturers, Provider Networks, and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Dialysis Device Key Manufacturers, Provider Networks, and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, dialysis population concentrations, facility and home-modality hotspots, installed-base replacement opportunities, and state-level commercial potential.

11. U.S. Dialysis Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Fresenius Medical Care
11.3.2. Vantive
11.3.3. B. Braun Medical
11.3.4. Nipro Medical Corporation
11.3.5. Nikkiso America
11.3.6. Outset Medical
11.3.7. Quanta Dialysis Technologies
11.3.8. Diality
11.3.9. DEKA Research & Development
11.3.10. Asahi Kasei Medical
11.3.11. Toray Medical
11.3.12. JMS North America
11.3.13. Medtronic
11.3.14. Becton, Dickinson and Company
11.3.15. AngioDynamics
11.3.16. Teleflex
11.3.17. Merit Medical Systems
11.3.18. Cook Medical
11.3.19. Medical Components, Inc. (Medcomp)
11.3.20. Nephros
11.3.21. Rockwell Medical
11.3.22. Mar Cor Purification
11.3.23. SeaStar Medical
11.3.24. Medline Industries
Note: Each company profile will include company overview, dialysis device and consumable portfolio, U.S. market strategy, financial positioning, clinical and regulatory pipeline, partnerships, provider relationships, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market share visibility, portfolio positioning, installed-base strategy, recurring-consumable exposure, innovation direction, and strategic intelligence on major dialysis device companies.

12. U.S. Dialysis Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Online High-Volume Hemodiafiltration
12.2.2. Compact and Integrated-Water Hemodialysis Platforms
12.2.3. Automated Home Dialysis and Remote Patient Management
12.2.4. Connected, Cybersecure, and Predictive Dialysis Systems
12.2.5. Specialty Acute Kidney Injury Filters and Therapeutic Cartridges
12.3. Emerging Business Trends
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
What this section provides: This section prepares clients for future modality shifts, technology disruption, provider-network changes, investment opportunities, and potential adoption scenarios through 2035.

13. U.S. Dialysis Devices Market: Strategic Recommendations

13.1. Recommendations for Dialysis Device and Consumable Manufacturers
13.2. Recommendations for Dialysis Providers, Hospitals, and Health Systems
13.3. Recommendations for Investors and Private Equity Firms
13.4. Recommendations for Distributors, GPOs, and Channel Partners
13.5. Recommendations for New Entrants and Renal-Technology Startups
13.6. Go-to-Market Strategy Considerations
13.7. Product Positioning, Service Infrastructure, and Portfolio Expansion Guidance
What this section provides: This section converts market intelligence into actionable strategy for growth planning, product positioning, provider contracting, service expansion, channel development, investment decisions, and competitive differentiation.

14. U.S. Dialysis Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s market boundaries, limitations, legal conditions, data-use terms, and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Dialysis Devices Market: Market Definition and Scope
TABLE 3: U.S. Dialysis Devices Market: Research Methodology Framework
TABLE 4: U.S. Dialysis Devices Market: Key Assumptions
TABLE 5: U.S. Dialysis Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Dialysis Devices Market: Stakeholder Analysis
TABLE 7: U.S. Dialysis Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Dialysis Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Dialysis Devices Market: Market Attractiveness Index
TABLE 10: U.S. Dialysis Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Dialysis Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Dialysis Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Dialysis Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Dialysis Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Dialysis Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Dialysis Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Dialysis Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Dialysis Devices Market: Dialysis Clinical Workflow Economics Matrix
TABLE 19: U.S. Dialysis Devices Market: Hospital and Provider Capital Procurement Behavior Matrix
TABLE 20: U.S. Dialysis Devices Market: PESTEL Analysis
TABLE 21: U.S. Dialysis Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Dialysis Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Dialysis Devices Market: Value Chain Analysis
TABLE 24: U.S. Dialysis Devices Market: Supply Chain Analysis
TABLE 25: U.S. Dialysis Devices Market: Digitalization and Connected Renal Care Impact
TABLE 26: U.S. Dialysis Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Dialysis Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Dialysis Devices Market: CMS ESRD Reimbursement and Coverage Landscape
TABLE 29: U.S. Dialysis Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Dialysis Devices Market: Government Initiatives and Kidney Health Programs
TABLE 31: U.S. Dialysis Devices Market: Impact of Escalating Geopolitical and Supply-Chain Tensions
TABLE 32: U.S. Dialysis Devices Market: Dialysis Provider and Hospital Value Analysis Decision Framework
TABLE 33: U.S. Dialysis Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Dialysis Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Dialysis Devices Market: Hemodialysis Machines and Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Dialysis Devices Market: Dialyzers and Hemofilters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Dialysis Devices Market: Bloodlines, Tubing Sets, Needles, and Treatment Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Dialysis Devices Market: Dialysate Delivery, Concentrates, and Water-Treatment Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Dialysis Devices Market: Peritoneal Dialysis Devices and Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Dialysis Devices Market: Continuous Kidney Replacement and Acute Dialysis Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Dialysis Devices Market: Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Dialysis Devices Market: Modality Snapshot, 2025
TABLE 45: Segment Dashboard; Definition and Scope, by Modality
TABLE 46: U.S. Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 47: U.S. Dialysis Devices Market: Segment Share Analysis, by Modality, 2025 & 2035 (%)
TABLE 48: U.S. Dialysis Devices Market: In-Center Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Dialysis Devices Market: Home Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Dialysis Devices Market: Peritoneal Dialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Dialysis Devices Market: Acute Intermittent Dialysis, SLED, and Continuous Kidney Replacement Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Dialysis Devices Market: Application Snapshot, 2025
TABLE 53: Segment Dashboard; Definition and Scope, by Application
TABLE 54: U.S. Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 55: U.S. Dialysis Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 56: U.S. Dialysis Devices Market: Chronic End-Stage Kidney Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Dialysis Devices Market: Acute Kidney Injury Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Dialysis Devices Market: Critical-Care and Multi-Organ Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Dialysis Devices Market: Pediatric and Specialty Renal Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Dialysis Devices Market: End User Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by End User
TABLE 62: U.S. Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 63: U.S. Dialysis Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 64: U.S. Dialysis Devices Market: Freestanding Dialysis Centers and Large Provider Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Dialysis Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Dialysis Devices Market: Home Care Programs and Patients Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Dialysis Devices Market: Academic Medical Centers and Specialty Kidney Programs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Dialysis Devices Market: Government, Veterans, and Public-Sector Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Dialysis Devices Market: Technology Type Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 71: U.S. Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 72: U.S. Dialysis Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 73: U.S. Dialysis Devices Market: Conventional High-Flux Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Dialysis Devices Market: Online Hemodiafiltration Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Dialysis Devices Market: Portable, Compact, and Integrated-Water Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Dialysis Devices Market: Automated Peritoneal Dialysis and Remote Patient Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Dialysis Devices Market: Connected and Predictive Dialysis Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Dialysis Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Dialysis Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Dialysis Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Dialysis Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Dialysis Devices Market: Key Manufacturers, Provider Networks, and Procurement Ecosystem
TABLE 84: West Region U.S. Dialysis Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 90: California Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 91: California Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 92: California Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 93: California Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 94: California Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 95: Washington Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 96: Washington Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 97: Washington Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 98: Washington Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 99: Washington Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 100: Arizona Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 101: Arizona Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 102: Arizona Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 103: Arizona Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: Arizona Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 105: Colorado Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 106: Colorado Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 107: Colorado Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 108: Colorado Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Colorado Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 110: Oregon Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 111: Oregon Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 112: Oregon Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 113: Oregon Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: Oregon Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 115: Utah Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Utah Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 117: Utah Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 118: Utah Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Utah Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 120: Nevada Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 121: Nevada Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 122: Nevada Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 123: Nevada Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 124: Nevada Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 125: New Mexico Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 130: Idaho Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 131: Idaho Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 132: Idaho Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 133: Idaho Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: Idaho Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 135: Montana Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 136: Montana Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 137: Montana Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 138: Montana Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: Montana Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 140: Wyoming Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 145: Alaska Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 146: Alaska Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 147: Alaska Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 148: Alaska Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 149: Alaska Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 150: Hawaii Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 155: Northeast Region U.S. Dialysis Devices Market: Regional Overview and Trends
TABLE 156: Northeast Region U.S. Dialysis Devices Market: Key Manufacturers, Provider Networks, and Procurement Ecosystem
TABLE 157: Northeast Region U.S. Dialysis Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Northeast Region U.S. Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 163: New York Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 164: New York Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 165: New York Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 166: New York Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 167: New York Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 168: Massachusetts Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 173: New Jersey Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 178: Pennsylvania Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 183: Connecticut Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 188: Maine Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 189: Maine Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 190: Maine Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 191: Maine Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 192: Maine Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 193: Vermont Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 194: Vermont Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 195: Vermont Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 196: Vermont Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 197: Vermont Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 198: New Hampshire Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 203: Rhode Island Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 208: Delaware Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 209: Delaware Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 210: Delaware Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 211: Delaware Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 212: Delaware Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 213: South Region U.S. Dialysis Devices Market: Regional Overview and Trends
TABLE 214: South Region U.S. Dialysis Devices Market: Key Manufacturers, Provider Networks, and Procurement Ecosystem
TABLE 215: South Region U.S. Dialysis Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 216: South Region U.S. Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 221: Texas Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 222: Texas Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 223: Texas Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 224: Texas Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 225: Texas Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 226: Florida Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 227: Florida Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 228: Florida Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 229: Florida Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 230: Florida Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 231: Georgia Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 232: Georgia Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 233: Georgia Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 234: Georgia Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 235: Georgia Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 236: North Carolina Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 241: Tennessee Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 246: South Carolina Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 251: Alabama Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 252: Alabama Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 253: Alabama Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 254: Alabama Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 255: Alabama Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 256: Mississippi Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 261: Louisiana Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 266: Arkansas Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 271: Kentucky Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 276: Oklahoma Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 281: Virginia Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 282: Virginia Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 283: Virginia Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 284: Virginia Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 285: Virginia Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 286: Maryland Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 287: Maryland Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 288: Maryland Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 289: Maryland Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 290: Maryland Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 291: West Virginia Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 296: Midwest Region U.S. Dialysis Devices Market: Regional Overview and Trends
TABLE 297: Midwest Region U.S. Dialysis Devices Market: Key Manufacturers, Provider Networks, and Procurement Ecosystem
TABLE 298: Midwest Region U.S. Dialysis Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 299: Midwest Region U.S. Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 300: Midwest Region U.S. Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 304: Illinois Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 305: Illinois Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 306: Illinois Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 307: Illinois Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 308: Illinois Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 309: Ohio Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 310: Ohio Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 311: Ohio Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 312: Ohio Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 313: Ohio Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 314: Michigan Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 315: Michigan Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 316: Michigan Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 317: Michigan Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 318: Michigan Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 319: Minnesota Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 320: Minnesota Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 324: Indiana Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 325: Indiana Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 326: Indiana Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 327: Indiana Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 328: Indiana Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 329: Wisconsin Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 330: Wisconsin Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 334: Missouri Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 335: Missouri Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 336: Missouri Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 337: Missouri Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 338: Missouri Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 339: Iowa Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 340: Iowa Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 341: Iowa Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 342: Iowa Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 343: Iowa Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 344: Kansas Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 345: Kansas Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 346: Kansas Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 347: Kansas Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 348: Kansas Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 349: Nebraska Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 350: Nebraska Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 354: North Dakota Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 355: North Dakota Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 359: South Dakota Dialysis Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 360: South Dakota Dialysis Devices Market, by Modality, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Dialysis Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Dialysis Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Dialysis Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 364: U.S. Dialysis Devices Market: Competitive Landscape Snapshot, 2025
TABLE 365: U.S. Dialysis Devices Market: Key Company Market Share Analysis, 2025
TABLE 366: U.S. Dialysis Devices Market: Company Positioning Matrix
TABLE 367: U.S. Dialysis Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 368: U.S. Dialysis Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 369: Fresenius Medical Care: Company Profile
TABLE 370: Vantive: Company Profile
TABLE 371: B. Braun Medical: Company Profile
TABLE 372: Nipro Medical Corporation: Company Profile
TABLE 373: Nikkiso America: Company Profile
TABLE 374: Outset Medical: Company Profile
TABLE 375: Quanta Dialysis Technologies: Company Profile
TABLE 376: Diality: Company Profile
TABLE 377: DEKA Research & Development: Company Profile
TABLE 378: Asahi Kasei Medical: Company Profile
TABLE 379: Toray Medical: Company Profile
TABLE 380: JMS North America: Company Profile
TABLE 381: Medtronic: Company Profile
TABLE 382: Becton, Dickinson and Company: Company Profile
TABLE 383: AngioDynamics: Company Profile
TABLE 384: Teleflex: Company Profile
TABLE 385: Merit Medical Systems: Company Profile
TABLE 386: Cook Medical: Company Profile
TABLE 387: Medical Components, Inc. (Medcomp): Company Profile
TABLE 388: Nephros: Company Profile
TABLE 389: Rockwell Medical: Company Profile
TABLE 390: Mar Cor Purification: Company Profile
TABLE 391: SeaStar Medical: Company Profile
TABLE 392: Medline Industries: Company Profile
TABLE 393: U.S. Dialysis Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 394: U.S. Dialysis Devices Market: Disruptive Technologies Impact Matrix
TABLE 395: U.S. Dialysis Devices Market: Emerging Business Trends
TABLE 396: U.S. Dialysis Devices Market: Business Opportunities for Startups and Existing Players
TABLE 397: U.S. Dialysis Devices Market: Investment Prioritization Matrix
TABLE 398: U.S. Dialysis Devices Market: Strategic Recommendations for Dialysis Device and Consumable Manufacturers
TABLE 399: U.S. Dialysis Devices Market: Strategic Recommendations for Dialysis Providers, Hospitals, and Health Systems
TABLE 400: U.S. Dialysis Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 401: U.S. Dialysis Devices Market: Strategic Recommendations for Distributors, GPOs, and Channel Partners
TABLE 402: U.S. Dialysis Devices Market: Strategic Recommendations for New Entrants and Renal-Technology Startups
TABLE 403: U.S. Dialysis Devices Market: Go-to-Market Strategy Considerations
TABLE 404: U.S. Dialysis Devices Market: Product Positioning, Service Infrastructure, and Portfolio Expansion Guidance
TABLE 405: U.S. Dialysis Devices Market: Scope Limitation
TABLE 406: U.S. Dialysis Devices Market: Data Use Limitation
TABLE 407: U.S. Dialysis Devices Market: Forecasting Limitation
TABLE 408: U.S. Dialysis Devices Market: Legal Disclaimer
TABLE 409: U.S. Dialysis Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Dialysis Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Dialysis Clinical Workflow Economics Framework
FIGURE 11: Dialysis Provider and Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Dialysis Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Dialysis Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Dialysis Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Hemodialysis Machines and Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Dialyzers and Hemofilters Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Bloodlines, Tubing Sets, Needles, and Treatment Disposables Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Dialysate Delivery, Concentrates, and Water-Treatment Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Peritoneal Dialysis Devices and Consumables Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Continuous Kidney Replacement and Acute Dialysis Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Vascular Access Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Modality Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Modality Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: In-Center Hemodialysis Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Home Hemodialysis Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Peritoneal Dialysis Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Acute Intermittent Dialysis, SLED, and Continuous Kidney Replacement Therapy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 31: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Chronic End-Stage Kidney Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Acute Kidney Injury Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Critical-Care and Multi-Organ Support Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Pediatric and Specialty Renal Support Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 37: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Freestanding Dialysis Centers and Large Provider Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Home Care Programs and Patients Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Academic Medical Centers and Specialty Kidney Programs Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Government, Veterans, and Public-Sector Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Conventional High-Flux Hemodialysis Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Online Hemodiafiltration Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Portable, Compact, and Integrated-Water Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Automated Peritoneal Dialysis and Remote Patient Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Connected and Predictive Dialysis Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Dialysis Devices Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Dialysis Devices Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Delaware Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Region U.S. Dialysis Devices Market Share and Leading Players, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Florida Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Georgia Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: North Carolina Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Tennessee Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Carolina Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Alabama Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Mississippi Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Louisiana Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Arkansas Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Kentucky Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Oklahoma Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Virginia Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Maryland Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Midwest Region U.S. Dialysis Devices Market Share and Leading Players, 2025
FIGURE 100: Midwest Region Market Share Analysis by State, 2025
FIGURE 101: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Illinois Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Ohio Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Michigan Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Minnesota Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Indiana Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Wisconsin Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Missouri Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Iowa Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Kansas Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Nebraska Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: North Dakota Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: South Dakota Dialysis Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 115: Company Positioning Matrix
FIGURE 116: Key Player Product Portfolio Benchmarking
FIGURE 117: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 118: Dialysis Device Innovation Roadmap
FIGURE 119: Home Dialysis Adoption Roadmap
FIGURE 120: Online High-Volume Hemodiafiltration Opportunity Map
FIGURE 121: Connected Dialysis and Remote Patient Management Growth Roadmap
FIGURE 122: Future Market Scenario Analysis, 2026–2035
FIGURE 123: Disruptive Technologies Impact Matrix
FIGURE 124: Emerging Business Trends Matrix
FIGURE 125: Investment Prioritization Matrix
FIGURE 126: Strategic Growth Roadmap for U.S. Dialysis Device Companies
FIGURE 127: Go-to-Market Strategy Framework
FIGURE 128: Product Positioning, Service Infrastructure, and Portfolio Expansion Framework
FIGURE 129: Report Scope and Disclaimer Framework